Plaquenil is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Hydroxychloroquine Sulfate.
| Product ID | 59212-562_0d2e78b8-8811-42a3-8554-73635e4e897f |
| NDC | 59212-562 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Plaquenil |
| Generic Name | Hydroxychloroquine Sulfate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-06-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA009768 |
| Labeler Name | Concordia Pharmaceuticals Inc. |
| Substance Name | HYDROXYCHLOROQUINE SULFATE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Antirheumatic Agent [EPC],Antimalarial [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2013-06-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA009768 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-06-28 |
| Marketing Category | NDA |
| Application Number | NDA009768 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-01-05 |
| Marketing Category | NDA |
| Application Number | NDA009768 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-06-28 |
| Marketing End Date | 2017-02-10 |
| Ingredient | Strength |
|---|---|
| HYDROXYCHLOROQUINE SULFATE | 200 mg/1 |
| SPL SET ID: | 34496b43-05a2-45fb-a769-52b12e099341 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68151-0511 | Plaquenil | Plaquenil |
| 43353-997 | Plaquenil | Plaquenil |
| 59212-562 | Plaquenil | Plaquenil |
| 67296-1781 | Plaquenil | Plaquenil |
| 71205-448 | Plaquenil | Plaquenil |
| 71610-473 | Plaquenil | Plaquenil |
| 0093-2401 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0143-2128 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0378-0373 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0591-3041 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0615-8218 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0615-8325 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0615-8374 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0615-8401 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0781-1407 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0781-5994 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0904-6508 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0904-6884 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 0904-7046 | HYDROXYCHLOROQUINE SULFATE | HYDROXYCHLOROQUINE SULFATE |
| 10544-578 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 16571-687 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate |
| 16714-110 | Hydroxychloroquine sulfate | Hydroxychloroquine sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PLAQUENIL 73662985 1470405 Live/Registered |
STERLING DRUG INC. 1987-05-26 |
![]() PLAQUENIL 72102433 0712043 Live/Registered |
Sterling Drug Inc. 1960-08-10 |
![]() PLAQUENIL 71618068 0562377 Live/Registered |
WINTHROP-STEARNS INC. 1951-08-24 |